MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.

Clinical trial NCT03611556 · COMPLETED

Trial details

NCT number: NCT03611556
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Carcinoma Metastatic Pancreatic Adenocarcinoma

Start date: 2018-06-21
Primary completion: 2022-07-22
Enrollment: 213

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.